A20E (p.Ala20Glu) variant of VCAN (Versican core protein)

A20E (p.Ala20Glu) in VCAN (Versican core protein) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes population frequency data and structural context.

A20E (p.Ala20Glu) variant details